My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

48.35 -0.52 (-1.05%)

Streaming Delayed Price Updated: 12:11 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Genentech to Present Data From One of the Most Comprehensive Oncology Portfolios at the 2021 ASCO Annual Meeting Showcasing Advancements for People Living With Cancer

May 11, 2021

From Genentech

Via Business Wire

Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗

May 10, 2021

Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:

Via Benzinga

Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com ↗

May 09, 2021

Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA...

Via Benzinga

Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip ↗

May 06, 2021

Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday. SKLZ shares closed 9% lower...

Via Benzinga

Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know ↗

May 07, 2021

Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...

Via Benzinga

India Gives Emergency Use Nod To Roche-Regeneron's COVID-19 Antibody Cocktail ↗

May 05, 2021

Roche Holdings AG (OTCMKTS: RHHBY) has received Emergency Use Authorization in India for its investigational antibody cocktail (casirivimab and imdevimab) for...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Cathie Wood Loaded Up Further On Skillz On Earnings Day ↗

May 05, 2021

Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $52.1 million, in Skillz Inc (NYSE: SKLZ) ahead of the mobile gaming company’s first-...

Via Benzinga

Cathie Wood Loads Up More On Alibaba Rivals Pinduoduo, JD — Also Adds Skillz ↗

May 04, 2021

Cathie Wood-led Ark Investment Management on Monday bought more shares of Pinduoduo Inc (NASDAQ: PDD) and JD.com Inc (NASDAQ: JD) — rivals to Alibaba Group Holding (...

Via Benzinga

Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies

May 03, 2021

Via FinancialNewsMedia

Topics Death

Biopharma Stocks Stall After Earnings, Lag Over 52 Weeks ↗

May 01, 2021

It is hard to forecast with the current choppy setting in the biopharma sector, but assuming that the COVID-19 vaccinations are on track in the U.S., financial results should improve for most large-cap...

Via Talk Markets

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

Another Heavy News Day ↗

April 29, 2021

For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.

Via Talk Markets

Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer ↗

April 29, 2021

The FDA’s Oncologic Drugs Advisory Committee voted 5-3 in favor of keeping Merck & Co’s (NYSE: MRK) Keytruda (pembrolizumab) accelerated approval...

Via Benzinga

Atea Pharma Stock Is Trading Higher As AT-527 Study In COVID-19 Moves Forward With Dosing ↗

April 29, 2021

Atea Pharmaceuticals Inc (NASDAQ: AVIR) has dosed the first patient in the Phase 3 MORNINGSKY trial evaluating AT-527 in mild or moderate COVID-19 patients in...

Via Benzinga

A Heavy News Day And Crypto ↗

April 28, 2021

Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today.

Via Talk Markets

FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech’s Tecentriq for Previously Untreated Metastatic Bladder Cancer

April 28, 2021

From Genentech

Via Business Wire

FDA Oncology Adcomm Votes To Keep Conditional Approval For Roche's Tecentriq In Place For Now ↗

April 28, 2021

The FDA kicked off a three-day meet to reexamine the accelerated approvals of immuno-oncology drugs with confirmatory trials that have not met their primary endpoint(s) and have...

Via Benzinga

FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech’s Tecentriq for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

April 27, 2021

From Genentech

Via Business Wire

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

Tuesday Market Report ↗

April 27, 2021

Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.

Via Talk Markets

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Disruptor Alert: These 2 Companies Are Changing Cancer Care ↗

April 24, 2021

Their liquid biopsies are giving doctors new and better tools to spot, track, and treat cancers.

Via The Motley Fool

Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion ↗

April 23, 2021

European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending approval of Roche Holdings AG’s (...

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Earth Day ↗

April 22, 2021

Once again the exchanges are unsure if they want to go up or down.

Via Talk Markets

Cathie Wood Loads Up Heavily On Debutant Uipath, Trims Tesla ↗

April 22, 2021

Cathie Wood-led Ark Investment Management on Wednesday snapped up millions of shares of the New York-based software automation company UiPath Inc (NYSE: PATH) on the day that it...

Via Benzinga

Gold Is Back ↗

April 21, 2021

Wednesday was another mixed day with oil stocks and foreign telcos up from demand rising--but US telcos going their own ways, with AT&T up, and Verizon down because it lost wireless subs.

Via Talk Markets

Roche Backs 2021 Outlook Despite Lackluster Q1 Performance In Pharmaceuticals Division ↗

April 21, 2021

Roche Holdings AG (OCTMKTS: RHHBY) posted Q1 sales of CHF 14.9 billion, up 3% Y/Y on a constant currency basis and down 1% on a reported basis. Sales in the...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.